Effect of a Simulated Flight in Patients With Type 2 Diabetes and Healthy Volunteers (FlyBar)

NHS Trust

Status: Completed

Conditions: Type 2 Diabetes

Treatments: Other: Hypoxia; Other: Low Humidity

Study type: Interventional

Funder types: Other

Identifiers

NCT04031417

R1276

Details and patient eligibility

About

Diabetes is an increasingly common condition which affects millions of people in the United Kingdom. Patients with type 2 diabetes are at increased risk to develop severe heart disease and vascular complications and these can result in death. A cornerstone of the treatment is lifestyle and diet.

The number of travellers is increasing quickly and there are more people than ever travelling by airplane. During a commercial flight the pressure of the air is lower than the pressure on the surface and that results in lower concentration of oxygen in the air we are breathing while flying. Also the humidity is very low inside an aircraft.

The aims of this study are to show if we can use a simulated flight as a method to look at how the endothelial cells react and to see if this is different between patients with type 2 diabetes mellitus and healthy volunteers.

A sub-study is also incorporated to look at different dietary interventions in type 2 diabetes.

Enrollment: 20 patients

Sex: All

Ages: 45 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

Diabetes group:

• Diagnosis of type 2 diabetes
• Patients on stable medication (for their diabetes metformin being the only treatment if any), for 3 months prior to entry into the study
• Age between 45-75 years at the start of the study; women need to be postmenopausal and not undergoing hormone replacement therapy (HRT)

Healthy volunteers group:

• No current disease or medication which would have effect on the safety of the subjects or interfere with the study results
• Age between 45-75 years at the start of the study; women need to be postmenopausal and not undergoing HRT

Exclusion criteria

• For both groups:

  • Patients with concurrent illness or any medication in the last 3 months that would interfere with the study based on the investigator's judgement
  • Acute coronary syndrome in the last 3 months or any major clinical event in the previous 3 months that would effect the study based on the investigator's judgement
  • Patients not wishing to allow disclosure to their general practitioner (GP)s.
  • HbA1c >9%
  • Smokers
  • Pre-menopausal women or post-menopausal women on HRT
  • Claustrophobia, panic attacks in the anamnesis
  • Subjects must not have been subjected to a commercial flight within 4 weeks of the study

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

20 participants in 3 patient groups

Placebo

Other group

Description:

Spend 2 hours in an environmental chamber at sea level conditions (temperature : 23c, oxygen concentration 21 %, humidity 45%) Spend 2 hours in a simulated flight (temperature 23c, oxygen concentration 15%, humidity 15%)

Treatment:

Other: Low Humidity

Other: Hypoxia

soy isoflavones

Other group

Description:

Spend 2 hours in an environmental chamber at sea level conditions (temperature : 23c, oxygen concentration 21 %, humidity 45%) Spend 2 hours in a simulated flight (temperature 23c, oxygen concentration 15%, humidity 15%)

Treatment:

Other: Low Humidity

Other: Hypoxia

soy isoflavones & cocoa polyphenols

Other group

Description:

Spend 2 hours in an environmental chamber at sea level conditions (temperature : 23c, oxygen concentration 21 %, humidity 45%) Spend 2 hours in a simulated flight (temperature 23c, oxygen concentration 15%, humidity 15%)

Treatment:

Other: Low Humidity

Other: Hypoxia